Tuning the Oxygen Reduction Reactivity of Layered Perovskites Using the Jahn-Teller Effect.

Compositional tuning of layered perovskite oxides provides a means of systematically studying how local distortions affect fundamental aspects of electrochemical reaction pathways. Structural analysis of a family of samples La1.2Sr0.8Ni1-yCoyO4 shows that Ni-rich compositions have an expanded crystalline c axis, which is anisotropically compressed by systematic Co incorporation. Raman spectra reveal the strong growth of a symmetry forbidden mode, which suggests that Co acts through localized distortions. Crystallographic and spectroscopic parameters describing this structural distortion correlate to the measured Tafel slopes for the oxygen reduction reaction for all Ni-containing samples, which is attributed to the distortion of potential energy surfaces by the Jahn-Teller expansion of d7 Ni(III) cations. Incorporation of Co not only minimizes the distortion but alters the apparent selectivity of the oxygen reduction reaction away from H2O2 and toward H2O. Rotating ring-disk electrochemical measurements, however, indicate that the apparent change in selectivity is due to activation of a first-order chemical disproportionation of H2O2 that is activated by Co in the lattice. These outcomes will support efforts to design electrocatalysts and reactors for the electrochemical synthesis of H2O2.

Raman Spectroscopic Analysis of the Reaction between Al-Si Coatings and Steel.

Hot-stamped ultrahigh strength steel components are pivotal to automotive light-weighting. Steel blanks, often coated with an aluminum-silicon (Al-Si) layer to protect them from oxidation and decarburization, are austenitized within a furnace and then simultaneously quenched and formed into shape. The Al-Si coating melts within the furnace and reacts with iron from the steel to yield an intermetallic phase that provides some long-term corrosion protection. During the intermediate liquid phase, some of the coating may transfer to the furnace components, leading to maintenance costs and operational downtime. A detailed understanding of the coating transformation mechanism is needed to avoid such production issues while ensuring that final intermetallic coatings conform to specifications. We introduce cross-sectional Raman microscopic mapping as a method to rapidly elucidate the coating transformation mechanism. Raman spectroscopic fingerprints for relevant intermetallic compounds were determined using synthesized Al-Fe-Si ternary and Al-Fe binary compounds. These fingerprints were used to map the spatial distribution of intermetallic compounds through cross sections of Al-Si-coated 22MnB5 specimens that were heated at temperatures between 570 and 900 °C. These chemical maps show that the intermetallic fraction of the coating does not grow significantly until formation of η (Al5Fe2) at the steel interface, suggesting that η facilitates extraction of iron from the steel and subsequent diffusion through the coating. Under the heating conditions used here, a series of reactions ultimately lead to a silicon-rich τ2 (Al3FeSi) phase on top of the binary η phase. The technique presented here simplifies structural analysis of intermetallic compounds, which will facilitate prototyping of strategies to optimize hot stamping.

Spherical DNA for Probing Wettability of Microplastics.

Wettability of microplastics may change due to chemical or physical transformations at their surface. In this work, we studied the adsorption of spherical nucleic acids (SNAs) with a gold nanoparticle core and linear DNA of the same sequence to probe the wettability of microplastics. Soaking microplastics in water at room temperature for 3 months resulted in the enhancement of SNA adsorption capacity and affinity, whereas linear DNA adsorption was the same on the fresh and soaked microplastics. Drying of the soaked microplastics followed by rehydration decreased the adsorption of the SNA, suggesting that the effect of soaking was reversible and related to physical changes instead of chemical changes of the microplastics. Raman spectroscopy data also revealed no chemical transformations of the soaked microplastics. Heating of microplastics over a short period induced a similar effect to long-term soaking. We propose that soaking or heating removes air entrapped in the nanosized pores at the water-plastic interface, increasing the contact surface area of the SNA to afford stronger adsorption. However, such wetted porosity would not change the adsorption of linear DNA because of its much smaller size.

Customizable Machine-Learning Models for Rapid Microplastic Identification Using Raman Microscopy.

Raman spectroscopy is commonly used in microplastics identification, but equipment variations yield inconsistent data structures that disrupt the development of communal analytical tools. We report a strategy to overcome the issue using a database of high-resolution, full-window Raman spectra. This approach enables customizable analytical tools to be easily created─a feature we demonstrate by creating machine-learning classification models using open-source random-forest, K-nearest neighbors, and multi-layer perceptron algorithms. These models yield >95% classification accuracy when trained on spectroscopic data with spectroscopic data downgraded to 1, 2, 4, or 8 cm-1 spacings in Raman shift. The accuracy can be maintained even in non-ideal conditions, such as with spectroscopic sampling rates of 1 kHz and when microplastic particles are outside the focal plane of the laser. This approach enables the creation of classification models that are robust and adaptable to varied spectrometer setups and experimental needs.

Differentiating Defects and Their Influence on Hematite Photoanodes Using X-ray Absorption Spectroscopy and Raman Microscopy.

A high degree of variability in behavior and performance of hematite as photoanodes for the oxygen evolution reaction signifies a need to improve our understanding of the interplay between defects and photoelectrochemical performance. We approach this problem by applying structure-property analysis to a series of hematite samples synthesized under either O2 or N2 environments such that they exhibit highly variable performance for photoelectrocatalytic oxygen evolution. X-ray absorption fine-structure spectroscopy and Raman spectroscopy provide parameters describing the structure of samples across the series. Systematic comparisons of these parameters to those describing photoelectrochemical performance reveal different defects in samples prepared under N2 or O2. Distinct correlations between both the iron oxidation state and charge carrier density with photoelectrocatalytic performance lead to assignment of the primary defects as oxygen vacancies (N2) and iron vacancies (O2). Differences in the structural distortions caused by these defects are seen in correlations between short-range structural parameters and photoelectrochemical behavior. These distortions are readily observed by Raman spectroscopy, suggesting that it may be possible to calibrate the width, energy, and intensity of peaks in Raman spectra to enable direct analysis of defects in hematite photoanodes.

Operando tracking of oxidation-state changes by coupling electrochemistry with time-resolved X-ray absorption spectroscopy demonstrated for water oxidation by a cobalt-based catalyst film.

Transition metal oxides are promising electrocatalysts for water oxidation, i.e., the oxygen evolution reaction (OER), which is critical in electrochemical production of non-fossil fuels. The involvement of oxidation state changes of the metal in OER electrocatalysis is increasingly recognized in the literature. Tracing these oxidation states under operation conditions could provide relevant information for performance optimization and development of durable catalysts, but further methodical developments are needed. Here, we propose a strategy to use single-energy X-ray absorption spectroscopy for monitoring metal oxidation-state changes during OER operation with millisecond time resolution. The procedure to obtain time-resolved oxidation state values, using two calibration curves, is explained in detail. We demonstrate the significance of this approach as well as possible sources of data misinterpretation. We conclude that the combination of X-ray absorption spectroscopy with electrochemical techniques allows us to investigate the kinetics of redox transitions and to distinguish the catalytic current from the redox current. Tracking of the oxidation state changes of Co ions in electrodeposited oxide films during cyclic voltammetry in neutral pH electrolyte serves as a proof of principle.

Analysis of Solid-State Reaction Mechanisms with Two-Dimensional Fourier Transform Infrared Correlation Spectroscopy.

The utility of two-dimensional generalized correlation spectroscopy (2D-COS) for tracking complex solid-state reactions is demonstrated using infrared spectra acquired during a photochemically induced decomposition reaction. Eleven different thin films, consisting of six monometallic and five bimetallic 2-ethylhexanoate complexes, were tracked as a function of photolysis time. Overlapping peaks in the infrared fingerprint region are readily discriminated using 2D-COS, enabling individual vibrational components to be used to distinguish whether carboxylate ligands are free/ionic or bound in a chelating, bridging, or monodentate fashion. This classification enables the decomposition mechanism to be tracked for all 11 samples, revealing that ligands bound in monodentate and bridging fashions are first converted to chelates before being lost as volatile products for all samples. The magnitude of the measured first-order rate constants for loss of chelated ligands is found to correlate linearly to the asymmetric stretching frequency of monodentate ligands but exhibits a V shape when plotted against the electronegativity of the metal center. We propose that loss of chelated ligands proceeds via C-O scission for highly electronegative transition metals but M-O scission for transition metals with low electronegativity. These results establish 2D-COS as a powerful tool to deconvolute and correlate individual components, enabling mechanistic analysis of complex chemical reactions.

Trapping a Photoelectron behind a Repulsive Coulomb Barrier in Solution.

Multiply charged anions (MCAs) display unique photophysics and solvent-stabilizing effects. Well-known aqueous species such as SO42- and PO43- experience spontaneous electron detachment or charge-separation fragmentation in the gas phase owing to the strong Coulomb repulsion arising from the excess of negative charge. Thus, anions often present low photodetachment thresholds and the ability to quickly eject electrons into the solvent via charge-transfer-to-solvent (CTTS) states. Here, we report spectroscopic evidence for the existence of a repulsive Coulomb barrier (RCB) that blocks the ejection of "CTTS-like" electrons of the aqueous B12F122- dianion. Our spectroscopic experimental and theoretical studies indicate that despite the exerted Coulomb repulsion by the nascent radical monoanion B12F12-•aq, the photoexcited electron remains about the B12F12-• core. The RCB is an established feature of the potential energy landscape of MCAs in vacuo, which seems to extend to the liquid phase highlighting recent observations about the dielectric behavior of confined water.

Structural and functional role of anions in electrochemical water oxidation probed by arsenate incorporation into cobalt-oxide materials.

Direct (photo)electrochemical production of non-fossil fuels from water and CO2 requires water-oxidation catalysis at near-neutral pH in the presence of appropriate anions that serve as proton acceptors. We investigate the largely enigmatic structural role of anions in water oxidation for the prominent cobalt-phosphate catalyst (CoCat), an amorphous and hydrated oxide material. Co3([(P/As)O]4)2·8H2O served, in conjunction with phosphate-arsenate exchange, as a synthetic model system. Its structural transformation was induced by prolonged operation at catalytic potentials and probed by X-ray absorption spectroscopy not only at the metal (Co), but for the first time also at the anion (As) K-edge. For initially isostructural microcrystals, anion exchange determined the amorphization process and final structure. Comparison to amorphous electrodeposited Co oxide revealed that in CoCat, the arsenate binds not only at oxide-layer edges, but also arsenic substitutes cobalt positions within the layered-oxide structure in an unusual AsO6 coordination. Our results show that in water oxidation catalysis at near-neutral pH, anion type and exchange dynamics correlate with the catalyst structure and redox properties.

H/D Isotope Effects Reveal Factors Controlling Catalytic Activity in Co-Based Oxides for Water Oxidation.

Understanding the mechanism for electrochemical water oxidation is important for the development of more efficient catalysts for artificial photosynthesis. A basic step is the proton-coupled electron transfer, which enables accumulation of oxidizing equivalents without buildup of a charge. We find that substituting deuterium for hydrogen resulted in an 87% decrease in the catalytic activity for water oxidation on Co-based amorphous-oxide catalysts at neutral pH, while 16O-to-18O substitution lead to a 10% decrease. In situ visible and quasi-in situ X-ray absorption spectroscopy reveal that the hydrogen-to-deuterium isotopic substitution induces an equilibrium isotope effect that shifts the oxidation potentials positively by approximately 60 mV for the proton coupled CoII/III and CoIII/IV electron transfer processes. Time-resolved spectroelectrochemical measurements indicate the absence of a kinetic isotope effect, implying that the precatalytic proton-coupled electron transfer happens through a stepwise mechanism in which electron transfer is rate-determining. An observed correlation between Co oxidation states and catalytic current for both isotopic conditions indicates that the applied potential has no direct effect on the catalytic rate, which instead depends exponentially on the average Co oxidation state. These combined results provide evidence that neither proton nor electron transfer is involved in the catalytic rate-determining step. We propose a mechanism with an active species composed by two adjacent CoIV atoms and a rate-determining step that involves oxygen-oxygen bond formation and compare it with models proposed in the literature.

Identifying protons trapped in hematite photoanodes through structure-property analysis.

Uncertainty regarding the nature of structural defects in hematite and their specific impacts on material properties and photoelectrocatalytic water oxidation inhibits their development as photoanodes. We perform structure-property analysis on a series of hematite films fabricated by annealing lepidocrocite films with varied temperatures, annealing times and atmospheres and find a gradient in the magnitude of a crystal lattice distortion by tracking the relative intensity of a formally Raman inactive vibrational mode. Structure-property analysis reveals that this feature in the Raman spectrum correlates to photocurrent density, semiconductor band positions, and the onset of photoelectrocatalysis. We propose that the onset of photoelectrocatalysis is linked to the location of defects that act as intraband recombination sites; an increase in the degree of structural distortion shifts these states towards the conduction band, thereby facilitating recombination. Analysis of the nature of the key Raman vibrations, X-ray diffraction patterns, and the synthetic conditions leads us to assign the distortion to iron vacancies that are induced by the trapping of protons within the crystal lattice. The ability to rapidly diagnose a specific structural defect will aid in the optimization of fabrication protocols for hematite photoanodes.

Spectroscopic identification of active sites for the oxygen evolution reaction on iron-cobalt oxides.

The emergence of disordered metal oxides as electrocatalysts for the oxygen evolution reaction and reports of amorphization of crystalline materials during electrocatalysis reveal a need for robust structural models for this class of materials. Here we apply a combination of low-temperature X-ray absorption spectroscopy and time-resolved in situ X-ray absorption spectroelectrochemistry to analyze the structure and electrochemical properties of a series of disordered iron-cobalt oxides. We identify a composition-dependent distribution of di-µ-oxo bridged cobalt-cobalt, di-µ-oxo bridged cobalt-iron and corner-sharing cobalt structural motifs in the composition series. Comparison of the structural model with (spectro)electrochemical data reveals relationships across the composition series that enable unprecedented assignment of voltammetric redox processes to specific structural motifs. We confirm that oxygen evolution occurs at two distinct reaction sites, di-µ-oxo bridged cobalt-cobalt and di-µ-oxo bridged iron-cobalt sites, and identify direct and indirect modes-of-action for iron ions in the mixed-metal compositions.

Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development.

Rituximab (MabThera®/Rituxan®), a chimeric murine/human monoclonal antibody that binds specifically to the transmembrane antigen CD20, was the first therapeutic antibody to enter clinical practice for the treatment of cancer. As monotherapy and in combination with chemotherapy, rituximab has been shown to prolong progression-free survival and, in some indications overall survival, in patients with various B-cell malignancies, while having a well-established and manageable safety profile and a wide therapeutic window. As a result, rituximab is considered to have revolutionized treatment practices for patients with B-cell malignancies. A subcutaneous (SC) formulation of rituximab has been developed, comprising the same monoclonal antibody as the originally marketed formulation [rituximab concentrate for solution for intravenous (IV) infusion], and has undergone a detailed, sequential clinical development program. This program demonstrated that, at fixed doses, rituximab SC achieves non-inferior serum trough concentrations in patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia, with comparable efficacy and safety relative to the IV formulation. The added benefit of rituximab SC was demonstrated in dedicated studies showing that rituximab SC allows for simplified and shortened drug preparation and administration times resulting in a reduced treatment burden for patients as well as improved resource utilization (efficiency) at the treatment facility. The improved efficiency of delivering rituximab's benefit to patients may broaden patient access to rituximab therapy in areas with low levels of healthcare resources, including IV-chair capacity constraints. This article is a companion paper to G. Salles, et al., which is also published in this issue. FUNDING: F. Hoffmann-La Roche Ltd.

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study.

Intravenous rituximab plus chemotherapy is standard treatment for diffuse large B-cell lymphoma. A subcutaneous formulation of rituximab is expected to simplify and shorten drug preparation and administration, and to reduce treatment burden. MabEase (clinicaltrials.gov Identifier: 01649856) examined efficacy, safety and patient satisfaction with subcutaneous rituximab plus chemotherapy in treatment-naïve patients with diffuse large B-cell lymphoma. Patients were randomized 2:1 to subcutaneous rituximab (intravenous 375 mg/m2 cycle 1; subcutaneous 1,400 mg cycles 2-8) or intravenous rituximab (375 mg/m2 cycles 1-8) plus cyclophosphamide, doxorubicin, vincristine, and prednisone every 14 or 21 days. The primary endpoint was investigator-assessed complete response/unconfirmed complete response. Secondary endpoints included safety, treatment satisfaction (Cancer Treatment Satisfaction Questionnaire and Rituximab Administration Satisfaction Questionnaire), time savings, and survival. Of 576 randomized patients, 572 (378 subcutaneous; 194 intravenous) received treatment. End of induction complete response/unconfirmed complete response rates were 50.6% (subcutaneous) and 42.4% (intravenous). After a median 35 months, median overall, event-free and progression-free survivals were not reached. Grade ≥3 adverse events (subcutaneous 58.3%; intravenous 54.3%) and administration-related adverse events (both groups 21%) were similar between arms. Injection-site reactions were more common with subcutaneous injections (5.7% versus 0%, respectively). Rituximab Administration Satisfaction Questionnaire scores for 'impact on activities of daily living', 'convenience', and 'satisfaction' were improved with subcutaneous versus intravenous injections; Cancer Therapy Satisfaction Questionnaire scores were similar between arms. Median administration time (6 minutes vs 2.6 to 3.0 hours), chair/bed and overall hospital times were shorter with subcutaneous versus intravenous rituximab. Overall, subcutaneous and intravenous rituximab had similar efficacy and safety, with improved patient satisfaction and time savings.

Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders.

PI3Kδ plays an important role controlling immune cell function and has therefore been identified as a potential target for the treatment of immunological disorders. This article highlights our work toward the identification of a potent, selective, and efficacious PI3Kδ inhibitor. Through careful SAR, the successful replacement of a polar pyrazole group by a simple chloro or trifluoromethyl group led to improved Caco-2 permeability, reduced Caco-2 efflux, reduced hERG PC activity, and increased selectivity profile while maintaining potency in the CD69 hWB assay. The optimization of the aryl substitution then identified a 4'-CN group that improved the human/rodent correlation in microsomal metabolic stability. Our lead molecule is very potent in PK/PD assays and highly efficacious in a mouse collagen-induced arthritis model.

Accounting for the Dynamic Oxidative Behavior of Nickel Anodes.

The dynamic behavior of the anodic peak for amorphous nickel oxy/hydroxide (a-NiOx) films in basic media was investigated. Chronocoulometry of films with known nickel concentrations reveals that a total of four electrons per nickel site comprise the signature anodic peak at 1.32 V during the first oxidative scan, and two electrons are passed through the associated cathodic peak on the reverse scan. The anodic and cathodic signals each contain two electrons on the successive scans. Catalytic oxygen evolution reaction (OER) was detected within the anodic peak, which is at a lower potential than is widely assumed. In order to rationalize these experimental results, we propose that the four-electron oxidation event is the conversion of the film from nickel(II) hydroxide ([Ni(II)-OH](-)) to a higher valent nickel peroxide species (e.g., Ni(IV)-OO or Ni(III)-OO·). The subsequent reduction of the nickel peroxide species is confined by a chemical step resulting in the accumulation of [Ni(II)-OOH](-), which is then oxidized by two electrons to form Ni(IV)-OO during the subsequent oxidative scan on the time scale of a cyclic voltammetric experiment. Our proposed mechanism and the experimental determination that each nickel site is oxidized by four electrons helps link the myriad of seemingly disparate literature data related to OER catalysis by nickel electrodes. The faster catalysis that occurs at higher oxidative potentials is derived from a minority species and is not elaborated here.

Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer.

BACKGROUND: Oleic Acid (OA) has been shown to have anticancer properties mediated by interaction with proteins such as α-lactalbumin and lactoferrins. Therefore, we synthesized complexes of OA and Gc protein-derived macrophage activating factor (GcMAF) that inhibits per se cancer cell proliferation and metastatic potential. We hypothesised that OA-GcMAF complexes could exploit the anticancer properties of both OA and GcMAF in a synergistic manner. We postulated that the stimulating effects of GcMAF on macrophages might lead to release of nitric oxide (NO). PATIENTS AND METHODS: Patients with advanced cancer were treated at the Immuno Biotech Treatment Centre with OA-GcMAF-based integrative immunotherapy in combination with a low-carbohydrate, high-protein diet, fermented milk products containing naturally-produced GcMAF, Vitamin D3, omega-3 fatty acids and low-dose acetylsalicylic acid. RESULTS: Measuring the tumour by ultrasonographic techniques, we observed a decrease of tumour volume of about 25%. CONCLUSION: These observations demonstrate that OA, GcMAF and NO can be properly combined and specifically delivered to advanced cancer patients with significant effects on immune system stimulation and tumour volume reduction avoiding harmful side-effects.

GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients.

α-N-acetylgalactosaminidase (nagalase) accumulates in the serum of cancer patients and its activity correlates with tumor burden, aggressiveness and clinical disease progression. The administration of GC protein-derived macrophage-activating factor (GcMAF) to cancer patients with elevated levels of nagalase has been associated with a decrease of serum nagalase activity and with significant clinical benefits. Here, we report the results of the administration of GcMAF to a heterogeneous cohort of patients with histologically diverse, advanced neoplasms, generally considered as "incurable" diseases. In most cases, GcMAF therapy was initiated at late stages of tumor progression. As this is an open-label, non-controlled, retrospective analysis, caution must be employed when establishing cause-effect relationships between the administration GcMAF and disease outcome. However, the response to GcMAF was generally robust and some trends emerged. All patients (n = 20) presented with elevated serum nagalase activity, well above normal values. All patients but one showed a significant decrease of serum nagalase activity upon weekly GcMAF injections. Decreased nagalase activity was associated with improved clinical conditions and no adverse side effects were reported. The observations reported here confirm and extend previous results and pave the way to further studies aimed at assessing the precise role and indications for GcMAF-based anticancer immunotherapy.